Felimazole 1.25 mg 1.25 mg (Methimazole TABLET) 1.25 MG

Felimazole 1.25 mg tablets contain methimazole, a medication used to manage hyperthyroidism in cats. This oral treatment helps regulate thyroid hormone levels for feline health.

Strength

1.25 MG

Pack Size

100

Manufacturer / TM Owner

DECHRA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Felimazole 1.25 mg tablets are primarily used to treat hyperthyroidism in cats. This condition occurs when the thyroid gland produces excessive hormones, leading to symptoms like weight loss and increased appetite. Methimazole, the active ingredient, helps to reduce the production of these hormones, promoting better health and well-being in affected cats.

Side Effects

Common effects of Felimazole 1.25 mg tablets may include improved appetite, weight gain, and reduced symptoms of hyperthyroidism in cats. Some pets might experience mild side effects, such as vomiting or lethargy, which typically subside as the body adjusts to the medication.

Precautions & Warnings

Felimazole 1.25 mg tablets should be administered as directed by a veterinarian. It is important to monitor your cat for any adverse reactions and to follow the prescribed dosage. Store the tablets in a cool, dry place away from direct sunlight and keep them out of reach of children and pets.

Avoid Interactions

Felimazole 1.25 mg tablets may interact with other medications, including those that affect the thyroid or immune system. Always inform your veterinarian about any other medications or supplements your cat is taking to avoid potential interactions. Avoid giving this medication with foods or substances that may alter its effectiveness.

Frequently Asked Questions

Felimazole 1.25 mg tablets are used to manage hyperthyroidism in cats by regulating thyroid hormone levels.

Administer Felimazole 1.25 mg tablets orally, following the dosage instructions provided by your veterinarian.

Common side effects may include vomiting, lethargy, and changes in appetite, which usually subside as the body adjusts.

Consult your veterinarian before giving Felimazole 1.25 mg with other medications to avoid potential interactions.

Store Felimazole 1.25 mg tablets in a cool, dry place away from direct sunlight and keep them out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.